British Journal of Haematology · 2002 · 14 citations · 11 references
MedicineOncologyPathologyCancer GeneticsHematologic OncologyMolecular OncologyLymphoid NeoplasmsLymphoid Tissue PathologyLymphoid TumorsRelapsed DiseaseTumor ClassificationLymphoma ClassificationLymphoma Molecular ClassificationLymphoma RelapseNon-hodgkin Lymphoma TreatmentRearrangement ReactionsRelapsed Diffuse Large B-cell LymphomaRelapsed Lymphoid NeoplasmsRelapsed Non-hodgkin Lymphoma
Relapses in non-Hodgkin's lymphomas (NHL) could be due to the reappearance of the initial neoplasm or new primary tumours. Discrimination between the two events would allow a more targeted therapeutic approach. VDJ rearrangement was used as marker of clonality in metachronous biopsy specimens from 10 patients with relapsed B-NHL. Complimentary determining region 3 was amplified and sequenced. D-JH was identical in eight matched primary/secondary tumours, confirming the diagnosis of recurrence. In contrast, primary and secondary tumours in two patients were of different clonal origin. Our data indicate that VDJ analysis is a fundamental tool for identification of relapses in NHL.
11
Martin Ivanovski, Federico Silvestri, Gabriele Pozzato et al. · Blood · 1998 · 241 citations · Full text
Vallì De Re, Salvatore De Vita, A. Marzotto et al. · Blood · 2000 · 222 citations
Life Sciences, Immunology, Pathology +12